Carcinoembryonic antigen (CEA), first described by Phil Gold and Samuel Freedman in the 1960s, is oneof the earliest tumor markers identified, playing a role in cell adhesion, invasion and metastasis. This evidence concerns the gene CEACAM5 and neoplasm.